Reports and Findings
Glenn Pearson BA (Education) PhD Candidate Director of First Nations Strategy and Leadership; Head, First Nations Health and Equity Research Director of First Nations Strategy and Leadership; Head, First Nations Health and Equity Research Area of
Brad Carrington Fiona Farrant Shepherd Stanley BSc (Hons), PhD PhD FAA FASSA MSc MD FFPHM FAFPHM FRACP FRANZCOG HonDSc HonDUniv HonFRACGP HonMD HonFRCPCH HonLLB (honoris causa) Co-Head, Aboriginal Health and Wellbeing Honorary Research Associate
Investigators: Albert McNamara, Allan Kickett Snr, Brad Farrant, Carol Michie, Carrington Shepherd, Charmaine Pell, Cheryl Kickett-Tucker, Clair Scrine, Doris Hill, Fiona Stanley, Glenn Pearson, Kerry Hunt, Larissa Perry, Michael Wright, Millie
Carrington Shepherd PhD Honorary Research Associate Honorary Research Associate Areas of research expertise: Population health; Aboriginal and Torres Strait Islander health; Social inequalities in health; child mortality. Carrington is an Honorary
Carrington Shepherd PhD Honorary Research Associate Honorary Research Associate Areas of research expertise: Population health; Aboriginal and Torres Strait Islander health; Social inequalities in health; child mortality. Carrington is an Honorary
Carrington Fiona Shepherd Stanley PhD FAA FASSA MSc MD FFPHM FAFPHM FRACP FRANZCOG HonDSc HonDUniv HonFRACGP HonMD HonFRCPCH HonLLB (honoris causa) Honorary Research Associate Patron 08 6319 1176 contact@thekids.org.au Honorary Research Associate
Carrington Fiona Shepherd Stanley PhD FAA FASSA MSc MD FFPHM FAFPHM FRACP FRANZCOG HonDSc HonDUniv HonFRACGP HonMD HonFRCPCH HonLLB (honoris causa) Honorary Research Associate Patron 08 6319 1176 contact@thekids.org.au Honorary Research Associate
Tissue resident memory T cells are cancer killing immune cells that have emerged as key players in immune-mediated control of solid cancers, as well as being markers of prognosis and predictors of response to immunotherapy.
In this project, we are using systems biology approaches to map the wound healing response in sarcoma following surgery to identify new treatments that can prevent sarcoma relapse.
We are developing a gel that can be left behind in the wound bed after sarcoma surgery.